These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. SATB1 Defines a Subtype of Cutaneous CD30 Sun J; Yi S; Qiu L; Fu W; Wang A; Liu F; Wang L; Wang T; Chen H; Wang L; Kadin ME; Tu P; Wang Y J Invest Dermatol; 2018 Aug; 138(8):1795-1804. PubMed ID: 29510190 [TBL] [Abstract][Full Text] [Related]
6. Results of a Phase II Trial of Brentuximab Vedotin for CD30+ Cutaneous T-Cell Lymphoma and Lymphomatoid Papulosis. Duvic M; Tetzlaff MT; Gangar P; Clos AL; Sui D; Talpur R J Clin Oncol; 2015 Nov; 33(32):3759-65. PubMed ID: 26261247 [TBL] [Abstract][Full Text] [Related]
8. Management of multifocal primary cutaneous CD30 anaplastic large cell lymphoma. Shehan JM; Kalaaji AN; Markovic SN; Ahmed I J Am Acad Dermatol; 2004 Jul; 51(1):103-10. PubMed ID: 15243534 [TBL] [Abstract][Full Text] [Related]
9. MUM1 expression in cutaneous CD30+ lymphoproliferative disorders: a valuable tool for the distinction between lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma. Kempf W; Kutzner H; Cozzio A; Sander CA; Pfaltz MC; Müller B; Pfaltz M Br J Dermatol; 2008 Jun; 158(6):1280-7. PubMed ID: 18410414 [TBL] [Abstract][Full Text] [Related]
10. CD30(+) cutaneous lymphoma in association with atopic eczema. Fletcher CL; Orchard GE; Hubbard V; Whittaker SJ; Edelson RL; Russell-Jones R Arch Dermatol; 2004 Apr; 140(4):449-54. PubMed ID: 15096373 [TBL] [Abstract][Full Text] [Related]
11. Methotrexate is effective therapy for lymphomatoid papulosis and other primary cutaneous CD30-positive lymphoproliferative disorders. Vonderheid EC; Sajjadian A; Kadin ME J Am Acad Dermatol; 1996 Mar; 34(3):470-81. PubMed ID: 8609262 [TBL] [Abstract][Full Text] [Related]
12. Associated Hematolymphoid Malignancies in Patients With Lymphomatoid Papulosis: A Canadian Retrospective Study. AbuHilal M; Walsh S; Shear N J Cutan Med Surg; 2017; 21(6):507-512. PubMed ID: 28614957 [TBL] [Abstract][Full Text] [Related]
13. Co-existent primary cutaneous anaplastic large cell lymphoma and lymphomatoid papulosis. Dawn G; Morrison A; Morton R; Bilsland D; Jackson R Clin Exp Dermatol; 2003 Nov; 28(6):620-4. PubMed ID: 14616830 [TBL] [Abstract][Full Text] [Related]
14. [Lymphomatoid papulosis type C or transition to CD30+-T-cell lymphoma? A difficult differential diagnosis]. Plettenberg H; Neumann NJ; Ruzicka T; Megahed M Hautarzt; 2003 Apr; 54(4):366-8. PubMed ID: 12669213 [TBL] [Abstract][Full Text] [Related]
15. Lymphomatoid papulosis: a follow-up study of 41 patients. Christensen HK; Thomsen K; Vejlsgaard GL Semin Dermatol; 1994 Sep; 13(3):197-201. PubMed ID: 7986688 [TBL] [Abstract][Full Text] [Related]
16. A case of lymphomatoid papulosis occurred simultaneously with Ki-1-positive anaplastic large cell lymphoma. Lee NS; Cha SW; Hong SJ; Shin WY; Lee GT; Jeon JW; Won JH; Baick SH; Hong DS; Park HS Korean J Intern Med; 1997 Jan; 12(1):84-8. PubMed ID: 9159045 [TBL] [Abstract][Full Text] [Related]
17. Pathology case of the month. A recurrent vesicle on the plantar aspect of the foot. Primary cutaneous CD30- positive T-cell lymphoproliferative disorder, consistent with lymphomatoid papulosis. Flamholz RB; Veillon DM; Nordberg ML; Cotelingam JD J La State Med Soc; 2004; 156(1):15-8. PubMed ID: 15000207 [No Abstract] [Full Text] [Related]